• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一株特别适应小鼠脊髓的脊髓灰质炎病毒突变体回复株的分子遗传学分析。

Molecular genetic analysis of revertants from a poliovirus mutant that is specifically adapted to the mouse spinal cord.

作者信息

Jia Q, Hogle J M, Hashikawa T, Nomoto A

机构信息

Department of Microbiology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.

出版信息

J Virol. 2001 Dec;75(23):11766-72. doi: 10.1128/JVI.75.23.11766-11772.2001.

DOI:10.1128/JVI.75.23.11766-11772.2001
PMID:11689657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC114762/
Abstract

SA virus, a mutant of the Mahoney strain of type 1 poliovirus (PV1/Mahoney), replicates specifically in the spinal cords of mice and causes paralysis, although the PV1/Mahoney strain does not show any mouse neurovirulence (Q. Jia, S. Ohka, K. Iwasaki, K. Tohyama, and A. Nomoto, J. Virol. 73:6041-6047, 1999). The key mutation site for the mouse neurovirulence of SA was mapped to nucleotide (nt) 928 of the genome (A to G), resulting in the amino acid substitution of Met for Ile at residue 62 within the capsid protein VP4 (VP4062). A small-plaque phenotype of SA appears to be indicative of its mouse-neurovirulent phenotype. To identify additional amino acid residues involved in the host range determination of PV, a total of 14 large-plaque (LP) variants were isolated from a single point mutant, Mah/I4062M, that showed the SA phenotype. All the LP variants no longer showed any mouse neurovirulence when delivered via an intraspinal inoculation route. Of these, 11 isolates had a back mutation at nt 928 (G to A) that restored the nucleotide of the PV1/Mahoney type. The reversions of the remaining three isolates (LP8, LP9, and LP14) were mediated by a second site mutation. Molecular genetic analysis involving recombinants between Mah/I4062M and the LP variants revealed that the mere substitution of an amino acid residue at position 107 in VP1 (Val to Leu) (LP9), position 33 in VP2 (Val to Ile) (LP14), or position 231 in VP3 (Ile to Thr) (LP8) was sufficient to restore the PV1/Mahoney phenotype. These amino acid residues are located either on the surface or inside of the virus particle. Our results indicate that the mouse neurovirulence of PV is determined by the virion surface structure, which is formed by all four capsid proteins.

摘要

SA病毒是1型脊髓灰质炎病毒(PV1/Mahoney)马奥尼株的突变体,它专门在小鼠脊髓中复制并导致瘫痪,尽管PV1/Mahoney株未显示出任何小鼠神经毒性(Q. Jia、S. Ohka、K. Iwasaki、K. Tohyama和A. Nomoto,《病毒学杂志》73:6041 - 6047,1999年)。SA小鼠神经毒性的关键突变位点被定位到基因组的核苷酸(nt)928(A到G),导致衣壳蛋白VP4内第62位氨基酸由异亮氨酸替换为甲硫氨酸(VP4062)。SA的小噬菌斑表型似乎表明其小鼠神经毒性表型。为了鉴定参与脊髓灰质炎病毒宿主范围决定的其他氨基酸残基,从表现出SA表型的单点突变体Mah/I4062M中总共分离出14个大噬菌斑(LP)变体。当通过脊髓内接种途径接种时,所有LP变体均不再显示任何小鼠神经毒性。其中,11个分离株在nt 928处发生了回复突变(G到A),恢复了PV1/Mahoney型的核苷酸。其余三个分离株(LP8、LP9和LP14)的回复是由第二位点突变介导的。涉及Mah/I4062M与LP变体之间重组体的分子遗传学分析表明,仅VP1中第107位氨基酸残基(缬氨酸替换为亮氨酸)(LP9)、VP2中第33位氨基酸残基(缬氨酸替换为异亮氨酸)(LP14)或VP3中第231位氨基酸残基(异亮氨酸替换为苏氨酸)(LP8)的替换就足以恢复PV1/Mahoney表型。这些氨基酸残基位于病毒颗粒的表面或内部。我们的结果表明脊髓灰质炎病毒的小鼠神经毒性由由所有四种衣壳蛋白形成的病毒粒子表面结构决定。

相似文献

1
Molecular genetic analysis of revertants from a poliovirus mutant that is specifically adapted to the mouse spinal cord.一株特别适应小鼠脊髓的脊髓灰质炎病毒突变体回复株的分子遗传学分析。
J Virol. 2001 Dec;75(23):11766-72. doi: 10.1128/JVI.75.23.11766-11772.2001.
2
Isolation and molecular characterization of a poliovirus type 1 mutant that replicates in the spinal cords of mice.一株能在小鼠脊髓中复制的1型脊髓灰质炎病毒突变体的分离与分子特征分析
J Virol. 1999 Jul;73(7):6041-7. doi: 10.1128/JVI.73.7.6041-6047.1999.
3
Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell.小鼠致病性1型脊髓灰质炎病毒马奥尼突变株的分子特征:衣壳蛋白壳内表面上的VP1和VP2多肽残基的作用
J Virol. 1993 Jul;67(7):3808-17. doi: 10.1128/JVI.67.7.3808-3817.1993.
4
Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro.1型脊髓灰质炎病毒LS-a株的小鼠神经毒力决定因素定位于衣壳蛋白VP1和蛋白酶2Apro的编码区域。
J Virol. 1994 Nov;68(11):7507-15. doi: 10.1128/JVI.68.11.7507-7515.1994.
5
Mutation of a single conserved nucleotide between the cloverleaf and internal ribosome entry site attenuates poliovirus neurovirulence.三叶草结构与内部核糖体进入位点之间单个保守核苷酸的突变会减弱脊髓灰质炎病毒的神经毒性。
J Virol. 2005 Nov;79(22):14235-43. doi: 10.1128/JVI.79.22.14235-14243.2005.
6
Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney type 1 strain a phenotype neurovirulent in mice.在人神经母细胞瘤细胞中筛选出的脊髓灰质炎病毒突变体衣壳中的替换,赋予了马奥尼1型毒株在小鼠中具有神经毒力的表型。
J Virol. 1994 Dec;68(12):8386-91. doi: 10.1128/JVI.68.12.8386-8391.1994.
7
A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA.1型脊髓灰质炎病毒RNA 5'非编码区内一个用于RNA复制的新型顺式作用元件。
J Virol. 1995 Nov;69(11):6825-32. doi: 10.1128/JVI.69.11.6825-6832.1995.
8
Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing.2型兰辛株脊髓灰质炎病毒小鼠神经毒力所需序列的定位
J Virol. 1986 Feb;57(2):515-25. doi: 10.1128/JVI.57.2.515-525.1986.
9
Expression of mutated poliovirus receptors in human neuroblastoma cells persistently infected with poliovirus.在持续感染脊髓灰质炎病毒的人神经母细胞瘤细胞中突变脊髓灰质炎病毒受体的表达。
Virology. 2000 Sep 1;274(2):331-42. doi: 10.1006/viro.2000.0462.
10
A new internal ribosomal entry site 5' boundary is required for poliovirus translation initiation in a mouse system.在小鼠系统中,脊髓灰质炎病毒翻译起始需要一个新的内部核糖体进入位点5'边界。
J Virol. 1998 Mar;72(3):2398-405. doi: 10.1128/JVI.72.3.2398-2405.1998.

本文引用的文献

1
Isolation and molecular characterization of a poliovirus type 1 mutant that replicates in the spinal cords of mice.一株能在小鼠脊髓中复制的1型脊髓灰质炎病毒突变体的分离与分子特征分析
J Virol. 1999 Jul;73(7):6041-7. doi: 10.1128/JVI.73.7.6041-6047.1999.
2
Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes.与抗病毒药物SCH48973复合的2型兰辛脊髓灰质炎病毒的结构:三种脊髓灰质炎病毒血清型的结构和生物学特性比较
Structure. 1997 Jul 15;5(7):961-78. doi: 10.1016/s0969-2126(97)00249-9.
3
Genetic analysis of internal ribosomal entry site on hepatitis C virus RNA: implication for involvement of the highly ordered structure and cell type-specific transacting factors.丙型肝炎病毒RNA内部核糖体进入位点的遗传分析:高度有序结构和细胞类型特异性反式作用因子参与的意义
Virology. 1997 Jun 23;233(1):9-18. doi: 10.1006/viro.1997.8600.
4
Poliovirus: new insights from an old paradigm.脊髓灰质炎病毒:旧范式中的新见解。
Structure. 1996 Jul 15;4(7):763-7. doi: 10.1016/s0969-2126(96)00082-2.
5
Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating.1型脊髓灰质炎病毒的小鼠适应性决定因素增强病毒脱壳。
J Virol. 1996 Jan;70(1):305-12. doi: 10.1128/JVI.70.1.305-312.1996.
6
A mutation in VP4 defines a new step in the late stages of cell entry by poliovirus.VP4 中的一种突变定义了脊髓灰质炎病毒进入细胞后期的一个新步骤。
J Virol. 1993 Aug;67(8):5075-8. doi: 10.1128/JVI.67.8.5075-5078.1993.
7
Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell.小鼠致病性1型脊髓灰质炎病毒马奥尼突变株的分子特征:衣壳蛋白壳内表面上的VP1和VP2多肽残基的作用
J Virol. 1993 Jul;67(7):3808-17. doi: 10.1128/JVI.67.7.3808-3817.1993.
8
Characterization of poliovirus conformational alteration mediated by soluble cell receptors.可溶性细胞受体介导的脊髓灰质炎病毒构象改变的特征分析
Virology. 1993 Nov;197(1):501-5. doi: 10.1006/viro.1993.1621.
9
Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney type 1 strain a phenotype neurovirulent in mice.在人神经母细胞瘤细胞中筛选出的脊髓灰质炎病毒突变体衣壳中的替换,赋予了马奥尼1型毒株在小鼠中具有神经毒力的表型。
J Virol. 1994 Dec;68(12):8386-91. doi: 10.1128/JVI.68.12.8386-8391.1994.
10
Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor.可溶性受体抗性脊髓灰质炎病毒突变体可鉴定出控制与细胞受体相互作用的衣壳表面和内部残基。
EMBO J. 1994 Dec 15;13(24):5855-62. doi: 10.1002/j.1460-2075.1994.tb06930.x.